MOLECULAR EPIDEMIOLOGY FEATURES OF HBV/HDV CO-INFECTION IN KYRGYZSTAN

Cover Page


Cite item

Full Text

Abstract

One of the most serious health problems in the world are hepatotropic viruses that cause chronic liver disease. Hepatitis B virus is distributed globally; around 5% of the carriers are also infected with hepatitis delta virus. Co-infection or superinfection of hepatitis viruses B and D significantly associated with a much more severe liver disease, compared with infection only hepatitis B virus. However, examination of hepatitis virus B carriers for the presence of hepatitis D virus in most regions of the world is not mandatory. It should be noted that the complete genotype mapping of viruses hepatitis B and D isolated on the territory of the CIS and the countries of the former Soviet Union, there is not yet, despite the constantly ongoing works devoted genotyping hepatotropic virus in the territory of the Russian Federation and neighboring countries. Due to the fact that one of the prospective ways of spreading viruses is the “labor migration” the inhabitants of Central Asia in other countries, including the Russian Federation, there is a need to pay attention to the situation of viral hepatitis in the region. The aim of our study was to estimate the prevalence of genetic variants and characteristics of molecular epidemiology of chronic viral hepatitis co-infection B + D in Kyrgyzstan. The study involved 30 plasma samples from patients with chronic viral hepatitis B and D from different regions of Kyrgyzstan. Based on the phylogenetic analysis of the isolates showed that among patients examined HBV identified only D genotype. Based on the phylogenetic analysis of the isolates indicated that among the examined patients with chronic viral hepatitis B revealed only genotype D. It is shown prevalence of HBV subtype D1 (73.34%) compared to the HBV subtype D2 (3.33%) and D3 (23.33%). Revealed HDV genotype I with highly variable region of the gene encoding the delta antigen. The high similarity of some isolates with strains specific to neighboring countries endemic for hepatotropic viruses, as well as a dense clustering of other isolates may be an indication of numerous independent drifts of strains into the territory of the country. Also it can talk about the speed of evolution of the virus in a geographically isolated region as Kyrgyzstan. Identification of the propagation characteristics and endemics role in circulation of genotype of hepatitis B and D is great importance.

About the authors

A. V. Semenov

St. Petersburg Pasteur Institute;
Pavlov First St. Petersburg State Medical University;
North-West State Medical University named after I.I. Mechnikov

Email: fake@neicon.ru

PhD (Biology), Head of the Laboratory of Virology and Immunology HIV;

Associate Professor;

Associate Professor, Department of Clinical Laboratory Diagnostics,

St. Petersburg

Россия

Yu. V. Ostankova

St. Petersburg Pasteur Institute, St. Petersburg

Author for correspondence.
Email: shenna1@yandex.ru

Researcher, Laboratory of Molecular Immunology and Seroepidemiology,

197101, St. Petersburg, Mira str., 14

Россия

K. A. Nogoybaeva

Kyrgyz State Medical Institute of Retraining and Skills

Email: fake@neicon.ru

PhD (Medicine), Associate Professor, Department of Infectious Diseases, Dermatology, HIV/AIDS,

Bishkek

Киргизия

K. T. Kasymbekova

Kyrgyz State Medical Institute of Retraining and Skills

Email: fake@neicon.ru

PhD, MD (Medicine), Professor, Head of Centre of Molecular-Genetic and Microbiological Investigations,

Bishkek

Киргизия

I. N. Lavrentieva

St. Petersburg Pasteur Institute

Email: fake@neicon.ru

PhD, MD (Medicine), Head of the Laboratory of Childhood Virus Infection,

St. Petersburg

Россия

S. T. Tobokalova

Kyrgyz State Medical Institute of Retraining and Skills

Email: fake@neicon.ru

PhD, MD (Medicine), Professor, Head of the Department of Infectious Diseases, Dermatology, HIV/AIDS,

Bishkek

Киргизия

Areg A. Totolian

St. Petersburg Pasteur Institute;
Pavlov First St. Petersburg State Medical University

Email: fake@neicon.ru

Corresponding Member of RAS, PhD, MD (Medicine), Professor, Head of the Laboratory of Molecular Immunology and Seroepidemiology;

Head of the Department of Immunology,

St. Petersburg

Россия

References

  1. Иванова Л.Ю. Информированность трудовых мигрантов из разных регионов об опасных инфекционных заболеваниях: ВИЧ, ИППП, туберкулез, гепатит (на материалах опроса иностранных работников в Санкт-Петербурге // Социальные аспекты здоровья населения. 2015. Т. 4, № 44. [Ivanova L.Yu. Awareness of labor migrants from different regions about dangerous infectious diseases: HIV, STID, tuberculosis, hepatitis (based on survey of foreign workers in St. Petersburg). Sotsial’nye aspekty zdorov’ya naseleniya = Social Aspects of Public Health, 2015, vol. 4, no. 44. (In Russ.)]. URL: http://vestnik.mednet.ru/content/view/702/30/lang.ru
  2. Мукомолов С.Л., Михайлов М.И. Применение иммуноглобулина против гепатита B для профилактики этой инфекции // Эпидемиология и инфекционные болезни. Актуальные вопросы. 2014. № 1. С. 47–54. [Mukomolov S.L., Mikhailov M.I. Use of immunoglobulin against hepatitis B to prevent this infection. Epidemiologiya i infektsionnye bolezni. Aktual’nye voprosy = Russian Journal of Epidemiology and Infectious Diseases. Topical issues. 2014, no. 1, pp. 47–54. (In Russ.)]
  3. Мукомолов С.Л., Левакова И.А. Эпидемиологическая характеристика хронических вирусных гепатитов в Российской Федерации в 1999–2009 гг. // Инфекция и иммунитет. 2011. Т. 1, № 3. С. 255–262. [Mukomolov S.L., Levakova I.A. Epidemiological characteristics of chronic viral hepatitis in the Russian Federation in 1999–2009. Infektsiya i immunitet = Russian Journal of Infection and Immunity, 2011, vol. 1, no. 3, pp. 255–262. doi: 10.15789/2220-7619-2011-3-255-262 (In Russ.)]
  4. Нечаев В.В., Мукомолов С.Л., Назаров В.Ю., Пожидаева Л.Н., Чахарьян В.В. Хронические вирусные гепатиты: прошлое, настоящее, будущее // Эпидемиология и инфекционные болезни. 2013. № 3. С. 4–10. [Nechaev V.V., Mukomolov S.L., Nazarov V.Yu., Pozhidaeva L.N., Chakhar’yan V.V. Chronic viral hepatitides: past, present, future. Epidemiologiya i infektsionnye bolezni = Russian Journal of Epidemiology and Infectious Diseases, 2013, vol. 3, pp. 4–10. (In Russ.)]
  5. Ногойбаева К.А., Тобокалова С.Т., Касымбекова К.Т., Заирова Г.М. Динамика заболеваемости хроническим гепатитом В в форме моноинфекции и в сочетании с гепатитом D в Кыргызской Республике за период 2010–2012 гг. // Казанский медицинский журнал. 2014. T. 95, № 6. С. 921–924. [Nogoybaeva K.A., Tobokalova S.T., Kasymbekova K.T., Zairova G.M. Trends for incidence of chronic hepatitis B monoinfection and chronic hepatitis B+D co-infection in the Kyrgyz Republic for the period of 2010–2012. Kazanskii meditsinskii zhurnal = Kazan Medical Journal, 2014, vol. 95, no. 6, pp. 921–924. (In Russ.)]
  6. Останкова Ю.В., Ногойбаева К.А., Семенов А.В., Тотолян Арег А. К вопросу о молекулярной эпидемиологии гепатита D в Кыргызстане // Медицинский академический журнал. 2015. Т. 15, № 2. С. 73–78. [Ostankova Yu.V., Nogoybaeva K.A., Semenov A.V., Totolian A.A. On molecular epidemiology of hepatitis D in Kyrgyzstan. Meditsinskii akademicheskii zhurnal = Medical Academic Journal, 2015, vol. 15, no. 2, pp. 73–78. (In Russ.)]
  7. Семенов А.В. Распространенность серонегативного гепатита D среди пациентов с хроническим вирусным гепатитом B // Журнал микробиологии, эпидемиологии и иммунобиологии. 2012. № 6. С. 106–109. [Semenov A.V. Prevalence of seronegative hepatitis D among patients with chronic viral hepatitis B. Zhurnal mikrobiologii, epidemiologii i immunobiologii = Journal of Microbiology, Epidemiology and Immunobiology, 2012, no. 6, pp. 106–109. (In Russ.)]
  8. Avazova D., Kurbanov F., Tanaka Y., Sugiyama M., Radchenko I., Ruziev D., Musabaev E., Mizokami M. Hepatitis B virus transmission pattern and vaccination efficiency in Uzbekistan. J. Med. Virol., 2008, vol. 80, no. 2, pp. 217–224. doi: 10.1002/jmv.21035
  9. Bissinger A.L., Fehrle C., Werner C.R., Lauer U.M., Malek N.P., Berg C.P. Epidemiology and genotyping of patients with chronic hepatitis B: genotype shifting observed in patients from Central Europe. Pol. J. Microbiol., 2015, vol. 64, no. 1, pp. 15–21.
  10. Brichler S., Lagathu G., Chekaraou M.A., Le Gal F., Edouard A., Dény P., Césaire R., Gordien E. African, amerindian and european hepatitis B virus strains circulate on the Caribbean Island of Martinique. J. Gen. Virol., 2013, vol. 94, no. 10, pp. 2318–2329. doi: 10.1099/vir.0.055459-0
  11. Casey J.L., Brown T.L., Colan E.J., Wignall F.S., Gerin J.L. A genotype of hepatitis D virus that occurs in northern South America. Proc. Natl. Acad. Sci. USA, 1993, vol. 90, no. 19, pp. 9016–9020.
  12. Chien R.N., Chiu K.W., Chu C.M., Liaw Y.F. Acute hepatitis in HBsAg carriers: comparisons among clinical features due to HDV superinfection and other etiologies. Chinese J. Gastroenterol., 1991, vol. 8, pp. 8–12. doi: 10.1016/S0168-8278(02)00419-1
  13. Chomczynski P., Sacchi N. The single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction: twenty-something years on. Nat. Protoc., 2006, vol. 1, no. 2, pp. 581–585. doi: 10.1038/nprot.2006.83
  14. Erhardt A., Blondin D., Hauck K., Sagir A., Kohnle T., Heintges T., Haussinger D. Response to interferon alfa is hepatitis B virus genotype dependent: genotype A is more sensitive to interferon than genotype D. Gut, 2005, vol. 54, pp. 1009–1013. doi: 10.1136/gut.2004.060327
  15. Fattovich G., Giustina G., Christensen E., Pantalena M., Zagni I., Realdi G., Schalm S.W. Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. The European concerted action on viral hepatitis (Eurohep). Gut, 2000, vol. 46, no. 3, pp. 420–426. doi: 10.1136/gut.46.3.420
  16. Fouad R., Abdo M., Gamal E.H., Sabry D., Atef M., Ahmed R., Zayed N. Influence of delta virus infection on the virologic status in Egyptian patients with chronic hepatitis B virus genotype D. J. Med. Virol., 2016, vol. 88, no. 5, pp. 837–842. doi: 10.1002/jmv.24412
  17. François-Souquière S., Makuwa M., Bisvigou U., Kazanji M. Epidemiological and molecular features of hepatitis B and hepatitis delta virus transmission in a remote rural community in central Africa. Infect. Genet. Evol., 2015, vol. 39, pp. 12–21. doi: 10.1016/j.meegid.2015.12.021
  18. Gheorghe L., Csiki I.E., Iacob S., Gheorghe C., Trifan A., Grigorescu M., Motoc A., Suceveanu A., Curescu M., Caruntu F., Sporea I., Brisc C., Rogoveanu I., Cerban R., Tugui L., Alexandrescu A. Hepatitis Delta virus infection in Romania: prevalence and risk factors. J. Gastrointestin. Liver Dis., 2015, vol. 24, no. 4, pp. 413–421. doi: 10.15403/jgld.2014.1121.244.dtv
  19. Higgins D.G., Bleasby A.J., Fuchs R. CLUSTAL V: improved software for multiple sequence alignment. Comput. Appl. Biosci., 1992, vol. 8, no. 2, pp. 189–191.
  20. Kato H., Ruzibakiev R., Yuldasheva N., Hegay T., Kurbanov F., Achundjanov B., Tuichiev L., Usuda S., Ueda R., Mizokami M. Hepatitis B virus genotypes in Uzbekistan and validity of two different systems for genotyping. J. Med. Virol., 2002, vol. 67, no. 4, pp. 477–483. doi: 10.1002/jmv.10126
  21. Kawakami J., Kumar P.K., Suh Y.A., Nishikawa F., Kawakami K., Taira K., Ohtsuka E., Nishikawa S. Identification of important bases in a single-stranded region (SSrC) of the hepatitis delta (delta) virus ribozyme. Eur. J. Biochem., 1993, vol. 217, no. 1, pp. 29–36. doi: 10.1111/j.1432-1033.1993.tb18214.x
  22. Khan A., Kurbanov F., Tanaka Y., Elkady A., Sugiyama M., Dustov A., Mizokami M. Epidemiological and clinical evaluation of hepatitis B, hepatitis C, and delta hepatitis viruses in Tajikistan. J. Med. Virol., 2008, vol. 80, no. 2, pp. 268–276. doi: 10.1002/jmv.21057
  23. Khedive A., Sanei-Moghaddam I., Alavian S.M., Saberfar E., Norouzi M., Judaki M., Ghamari S., Jazayeri S.M. Hepatitis B virus surface antigen (HBsAg) mutations are rare but clustered in immune epitopes in chronic carriers from Sistan-Balouchestan Province, Iran. Arch. Iran Med., 2013, vol. 16, no. 7, pp. 385–389. doi: 013167/AIM.005
  24. Mokdad A.A., Lopez A.D., Shahraz S., Lozano R., Mokdad A.H., Stanaway J., Murray C.J., Naghavi M. Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis. BMC Med., 2014, vol. 12, e:145. doi: 10.1186/s12916-014-0145-y.
  25. Ozaras R., Inanc B.I., Yemisen M., Tabak F. Epidemiology of HBV subgenotypes D. Clin. Res. Hepatol. Gastroenterol., 2015, vol. 39, no. 1, pp. 28–37. doi: 10.1016/j.clinre.2014.06.005
  26. Romeo R., Foglieni B., Casazza G., Spreafico M., Colombo M., Prati D. High serum levels of HDV RNA are predictors of cirrhosis and liver cancer in patients with chronic hepatitis delta. PLoS One, 2014, vol. 9, no. 3, e92062. doi: 10.1371/journal.pone.0092062
  27. Romeo R., Perbellini R. Hepatitis delta virus: making the point from virus isolation up to 2014. World J. Hepatol., 2015, vol. 7, no. 22, pp. 2389–2395. doi: 10.4254/wjh.v7.i22.2389
  28. Saitou N., Nei M. The neighbour-joining method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol., 1987, vol. 4, no. 4, pp. 406–425.
  29. Sambrook J., Fritsch E.F., Moniatis T. Molecular cloning: a laboratory manual. 2nd ed. New York: Cold Spring Harbor Laboratory Press, 1989, 2230 p.
  30. Stanojević B., Osiowy C., Schaefer S., Bojović K., Blagojević J., Nešić M., Yamashita S., Stamenković G. Molecular characterization and phylogenetic analysis of full-genome HBV subgenotype D3 sequences from Serbia. Infect. Genet. Evol., 2011, vol. 11, no. 6, pp. 1475–1480. doi: 10.1016/j.meegid.2011.05.004
  31. Tallo T., Tefanova V., Priimagi L., Schmidt J., Katargina O., Michailov M., Mukomolov S., Magnius L., Norder H. D2: major subgenotype of hepatitis B virus in Russia and the Baltic region. J. Gen. Virol., 2008, vol. 89, no. 8, pp. 1829–1839. doi: 10.1099/vir.0.83660-0
  32. Yuen M.F., Lai C.L. Hepatitis B virus genotypes: natural history and implications for treatment. Expert Rev. Gastroenterol. Hepatol., 2007, vol. 1, no. 2, pp. 321–328. doi: 10.1586/17474124.1.2.321
  33. Zabransky T., Mravcik V., Talu A., Jasaitis E. Post-Soviet Central Asia: a summary of the drug situation. Int. J. Drug. Policy, 2014, vol. 25, no. 6, pp. 1186–1194. doi: 10.1016/j.drugpo.2014.05.004
  34. Zehender G., Shkjezi R., Ebranati E., Gabanelli E., Abazaj Z., Tanzi E., Kraja D., Bino S., Ciccozzi M., Galli M. Reconstruction of the epidemic history of hepatitis B virus genotype D in Albania. Infect. Genet. Evol., 2012, vol. 12, no. 2, pp. 291–298. doi: 10.1016/j.meegid.2011.11.009

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2016 Semenov A.V., Ostankova Y.V., Nogoybaeva K.A., Kasymbekova K.T., Lavrentieva I.N., Tobokalova S.T., Totolian A.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 64788 от 02.02.2016.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies